EPRX

Eupraxia Pharmaceuticals (EPRX)

About Eupraxia Pharmaceuticals (EPRX)

Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell, John Salvatore Montalbano and Amanda Malone on May 12, 2011 and is headquartered in Victoria, Canada.

Details

Daily high

$6.31

Daily low

$6.04

Price at open

$6.11

52 Week High

$7.19

52 Week Low

$2.68

Market cap

312.0M

Dividend yield

0.00%

Volume

132,769

Avg. volume

121,884

P/E ratio

-7.09

Eupraxia Pharmaceuticals News